Enovix is trading at $2.79, down 5.10% during the November 4, 2026 session; no clear company-specific announcement explains the decline.

  • The company disclosed its chief legal officer’s departure on November 3; available reporting does not establish that it caused the share move.
  • Reuters reported U.S. stocks higher after the midterm results, so broad market direction alone does not explain Enovix’s decline.